Literature DB >> 19093115

Association of sickle avascular necrosis with bone morphogenic protein 6.

Pinar Ulug, Nisha Vasavda, Moji Awogbade, Juliette Cunningham, Stephan Menzel, Swee Lay Thein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19093115     DOI: 10.1007/s00277-008-0659-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  8 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  The search for genetic modifiers of disease severity in the β-hemoglobinopathies.

Authors:  Guillaume Lettre
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

Review 4.  Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.

Authors:  Alawi Habara; Martin H Steinberg
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-01

Review 5.  Sickle Cell Anemia and Its Phenotypes.

Authors:  Thomas N Williams; Swee Lay Thein
Journal:  Annu Rev Genomics Hum Genet       Date:  2018-04-11       Impact factor: 9.340

6.  Klotho: its various functions and association with sickle cell disease subphenotypes.

Authors:  Ana Paula Almeida de Souza Pacheco; Marilda Goncalves
Journal:  Rev Bras Hematol Hemoter       Date:  2014-10-05

7.  Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.

Authors:  Young Bin Joo; So-Young Bang; Tae-Hwan Kim; Seung-Cheol Shim; Seunghun Lee; Kyung Bin Joo; Jong Heon Kim; Hye Joon Min; Proton Rahman; Robert D Inman
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 8.  Genomic approaches to identifying targets for treating β hemoglobinopathies.

Authors:  Duyen A Ngo; Martin H Steinberg
Journal:  BMC Med Genomics       Date:  2015-07-29       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.